112 related articles for article (PubMed ID: 35937390)
1. ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma.
Li J; Yang D; Zhang C; Wei S; Zhao R; Dai S; Shan B
Biomed Res Int; 2022; 2022():5328192. PubMed ID: 35937390
[TBL] [Abstract][Full Text] [Related]
2. APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis.
Cao X; Wu B; Guo S; Zhong W; Zhu S; Zhang Z; Gu L; Li H
Pathol Oncol Res; 2023; 29():1610976. PubMed ID: 36969562
[No Abstract] [Full Text] [Related]
3. Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma.
Wang S; Xi J; Lin Z; Hao J; Yao C; Zhan C; Jiang W; Shi Y; Wang Q
Cancer Med; 2018 Apr; 7(4):1006-1018. PubMed ID: 29532618
[TBL] [Abstract][Full Text] [Related]
4. A2ML1 Inhibits Esophageal Squamous Cell Carcinoma Progression and Serves as a Novel Prognostic Biomarker.
Zhang X; Tang C; Lian J; Jiang Y
Can J Gastroenterol Hepatol; 2023; 2023():5557546. PubMed ID: 37954860
[TBL] [Abstract][Full Text] [Related]
5. High expression of PPFIA1 in human esophageal squamous cell carcinoma correlates with tumor metastasis and poor prognosis.
Gao Y; Guan L; Jia R; Xiao W; Han Y; Li Y; Tang P; Yu Z; Zhang H
BMC Cancer; 2023 May; 23(1):417. PubMed ID: 37158817
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of clinicopathological factors and survival between esophageal basaloid squamous cell carcinoma and conventional esophageal squamous cell carcinoma.
Jiang D; Wang H; Deng M; Song Q; Liu Y; Peng R; Xu L; Su J; Xu C; Hou Y
Eur J Surg Oncol; 2023 May; 49(5):958-963. PubMed ID: 36588005
[TBL] [Abstract][Full Text] [Related]
7. High FN1 expression is associated with poor survival in esophageal squamous cell carcinoma.
Ma J; Chen S; Su M; Wang W
Medicine (Baltimore); 2023 Apr; 102(14):e33388. PubMed ID: 37026938
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of CDK6 amplification in esophageal squamous cell carcinoma.
Liu K; Lu H; Jiang D; Guan Y; Xu H; Sun Q; Jiang Q; Zheng J; Chen H; Zhang F; Luo R; Huang Y; Xu J; Hou Y
Cancer Treat Res Commun; 2023; 35():100698. PubMed ID: 37023643
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of Nrf2/HO-1 expression and its correlation with occurrence in esophageal squamous cell carcinoma.
Gao Y; Li M; Wang B; Ma Y
Genes Genomics; 2023 Jun; 45(6):723-739. PubMed ID: 37043130
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma.
Jiang D; Song Q; Zhang F; Xu C; Li X; Zeng H; Su J; Huang J; Xu Y; Lu S; Hou Y
Cancer Genet; 2023 Nov; 278-279():1-8. PubMed ID: 37556965
[TBL] [Abstract][Full Text] [Related]
11. HSF1 expression in tumor-associated macrophages promotes tumor cell proliferation and indicates poor prognosis in esophageal squamous cell carcinoma.
Li Y; Li Q; Liu J; Huang Y; Mao J; Zhang G
Clin Transl Oncol; 2023 Jun; 25(6):1682-1689. PubMed ID: 36586067
[TBL] [Abstract][Full Text] [Related]
12. High expression of LGR6 is a poor prognostic factor in esophageal carcinoma.
Ehara T; Uehara T; Yoshizawa T; Kinugawa Y; Nakajima T; Kobayashi S; Asaka S; Iwaya M; Nagaya T; Kitazawa M; Ota H; Soejima Y
Pathol Res Pract; 2023 Feb; 242():154312. PubMed ID: 36701848
[TBL] [Abstract][Full Text] [Related]
13. Targeting ESM1/ VEGFα signaling axis: a promising therapeutic avenue for angiogenesis in cervical squamous cell carcinoma.
Li D; Su X; Xue S; Yao L; Yu D; Tang X; Huang Y
J Cancer; 2023; 14(10):1725-1735. PubMed ID: 37476182
[No Abstract] [Full Text] [Related]
14. Comprehensive analysis of cuproptosis genes and cuproptosis-related genes as prognosis factors in esophageal squamous cell carcinoma.
Wu Z; Huang Z; Zhou X; Gao C; Peng Z; Zheng X; Zhang Y; Du Z; Wu B
Genomics; 2023 Nov; 115(6):110732. PubMed ID: 37866660
[TBL] [Abstract][Full Text] [Related]
15. Validation of ESM1 Related to Ovarian Cancer and the Biological Function and Prognostic Significance.
Li YK; Zeng T; Guan Y; Liu J; Liao NC; Wang MJ; Chen KX; Luo XY; Chen CY; Quan FF; Wang J; Zhang QF; Zou J
Int J Biol Sci; 2023; 19(1):258-280. PubMed ID: 36594088
[No Abstract] [Full Text] [Related]
16. High endothelial venules associated with better prognosis in esophageal squamous cell carcinoma.
Li H; Tang L; Han X; Zhong L; Gao W; Chen Y; Huang J; Wen Z
Ann Diagn Pathol; 2022 Dec; 61():152051. PubMed ID: 36272333
[TBL] [Abstract][Full Text] [Related]
17. Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer.
He JZ; Chen Y; Zeng FM; Huang QF; Zhang HF; Wang SH; Yu SX; Pang XX; Liu Y; Xu XE; Wu JY; Shen WJ; Li ZY; Li EM; Xu LY
J Exp Clin Cancer Res; 2023 May; 42(1):136. PubMed ID: 37254126
[TBL] [Abstract][Full Text] [Related]
18. CDKL3 shapes immunosuppressive tumor microenvironment and initiates autophagy in esophageal cancer.
Bi Y; Liu J; Qin S; Ji F; Zhou C; Yang H; Zhou S
Front Immunol; 2024; 15():1295011. PubMed ID: 38562942
[TBL] [Abstract][Full Text] [Related]
19. Grading criteria for venous invasion in thoracic esophageal squamous cell carcinoma.
Wang A; Liu X; Lu L; Wang S; Chen X
J Cardiothorac Surg; 2023 Apr; 18(1):111. PubMed ID: 37029384
[TBL] [Abstract][Full Text] [Related]
20. Four transcription profile-based models identify novel prognostic signatures in oesophageal cancer.
Liu T; Fang P; Han C; Ma Z; Xu W; Xia W; Hu J; Xu Y; Xu L; Yin R; Wang S; Zhang Q
J Cell Mol Med; 2020 Jan; 24(1):711-721. PubMed ID: 31746108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
